MAIA Stock Analysis: Buy, Sell, or Hold?

MAIA - MAIA Biotechnology, Inc.

PHARMACEUTICAL PREPARATIONS
$1.43
0.08 (5.93%) ▲
5d: +9.16%
30d: +2.88%
90d: -8.33%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 08, 2026 0d

Get Alerted When MAIA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: MAIA trades at premium valuation expecting 30.6% growth. Hold existing positions but don't chase. Wait for better entry.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$0.94
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.58
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: MAIA is currently trading at $1.43, which is considered extended relative to its 30-day fair value range of $1.27 to $1.36. From a valuation perspective, the stock is trading at a premium (Forward PE: 1.3) compared to its historical average (0.6). At these levels, the market is pricing in 30.6% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.

Technical Outlook: Technically, MAIA is in a strong downtrend. Immediate support is located at $1.23, while resistance sits at $1.52. The stock is showing strong short-term momentum, up 5.9% recently.

Market Sentiment: MAIA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.13 (+748.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $1.27 - $1.36
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

All Signals

  • BEARISH: Price extended above range (+5.1% above its trading range)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+5.9%)
  • BULLISH: Trading 748.6% below Wall St target ($12.13)
  • BEARISH: Market expects 30.6% growth - appears too optimistic based on history

Trading Range Analysis

30-Day Trading Range $1.27 - $1.36
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $1.23
Resistance Level $1.52
Current Trend Strong Downtrend
Technical data as of Jun 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) 1.28
Wall Street Target $12.14 (+748.6%)
Valuation Premium vs History +30.6% premium
PE vs Historical 1.3 vs 0.6 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +30.6% (market-implied from PE analysis)
1-Year Target $1.87 (+31%)
2-Year Target $2.44 (+71%)
3-Year Target $3.19 (+123%)
3-Yr Target (if PE normalizes) (PE: 1→1) PE COMPRESSION $1.50 (+5%)
Earnings growth offset by PE compression
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 03, 2026 6:41 PM ET
Data refreshes hourly during market hours. Next update: 7:40 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 62 BUY
INCY
Incyte Corporation
HOLD
27 analysts
$108 56 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$123 50 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$102 52 HOLD

More Analysis for MAIA

MAIA Technical Chart MAIA Price Prediction MAIA Earnings Date MAIA Investment Advisor MAIA Fair Price Analyzer MAIA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals